http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 25 Feb 2026 07:00:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Press+Releases/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469 http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html <p> MISSISSAUGA, Ontario--(BUSINESS WIRE)-- Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 first quarter results for the period ended December 31, 2025, along with its recent achievements and highlights. Full financial statements and management discussion and analysis are available on the Company’s profile at <a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54432785&amp;newsitemid=20260225565323&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=1&amp;md5=6692297208a51fb78c866150da37625a" shape="rect">www.sedarplus.ca</a>. </p><p> Brent Ashton, Covalon’s Chief Executive Officer’s commented, “Covalon’s first quarter of fiscal 2026 delivered results just above a breakeven, reflecting normal quarter-to-quarter variability in the timing of orders received and shipments fulfilled. Notably, sales and orders received http://www.streetinsider.com/Business+Wire/Covalon+Reports+on+2026+First+Quarter+Results+and+Recent+Achievements+and+Highlights/26055079.html Wed, 25 Feb 2026 07:00:00 -0500 A.06822034 A.12270389 A.34824225 A.36078215 A.39615950 COV CVALF O.00007330 O.00417295 O.01582705 O.02555813 O.20026344 O.26772469